http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5846567-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c932d8eb8644906668acdb47cb77e603
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-40
filingDate 1997-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7f02aae65d51c51d1d1812c439e34b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6b8d4137b1ac7b8d3e6e39edd459b31
publicationDate 1998-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5846567-A
titleOfInvention Clot dissolving method
abstract A method, composition and kit for effecting hemostasis of a bleeding point and/or dissociating an adherent blood clot at a lesion site on an internal organ, include a composition comprising hydrogen peroxide and surfactant. The composition is applied to the site thereby effecting hemostasis and clot dissociation and clearing the field for endoscopy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8865770-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9707251-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009232877-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2741788-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8021355-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8852558-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1084706-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1084706-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8828358-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006224063-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8100888-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013025685-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2741788-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009232876-A1
priorityDate 1997-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4477438-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4198390-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5104644-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135928330
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129349967
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71336656

Total number of triples: 39.